Growth Metrics

Pfizer (PFE) Return on Assets (2016 - 2025)

Pfizer (PFE) has disclosed Return on Assets for 17 consecutive years, with 0.0% as the latest value for Q4 2025.

  • Quarterly Return on Assets changed 0.0% to 0.0% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.0% through Dec 2025, changed 0.0% year-over-year, with the annual reading at 0.0% for FY2025, 0.0% changed from the prior year.
  • Return on Assets for Q4 2025 was 0.0% at Pfizer, roughly flat from 0.0% in the prior quarter.
  • The five-year high for Return on Assets was 0.01% in Q2 2021, with the low at 0.0% in Q4 2021.
  • Average Return on Assets over 5 years is 0.0%, with a median of 0.0% recorded in 2022.
  • The sharpest move saw Return on Assets dropped -7bps in 2021, then changed 0bps in 2022.
  • Over 5 years, Return on Assets stood at 0.0% in 2021, then skyrocketed by 102bps to 0.0% in 2022, then plummeted by -302bps to 0.0% in 2023, then soared by 127bps to 0.0% in 2024, then soared by 549bps to 0.0% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.0%, 0.0%, and 0.0% for Q4 2025, Q3 2025, and Q2 2025 respectively.